Verigene Warfarin Metabolism Nucleic Acid Test Kit를 이용한 CYP2C9 및 VKORC1 유전형 분석능 평가
활용도 Analysis
논문 Analysis
연구자 Analysis
저자
이혜영
김지연
이건동
박준홍
채효진
김명신
김용구
오용석
제어번호
101598615
학술지명
Laboratory Medicine Online
권호사항
Vol.
4
No.
4
[
2014
]
발행처
대한진단검사의학회
자료유형
학술저널
수록면
198-202
언어
Korean
출판년도
2014
등재정보
KCI등재
판매처
'
Verigene Warfarin Metabolism Nucleic Acid Test Kit를 이용한 CYP2C9 및 VKORC1 유전형 분석능 평가' 의 참고문헌
Validation of clinical testing for warfarin sensitivity : comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements : proposal for a new dosing regimen
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose
King CR
Am J Clin Pathol 129 876-883
[2008]
Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin
Ma C
Int J Hematol 96 719-728
[2012]
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements
Genetic warfarin dosing : tables versus algorithms
Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
Cho HJ
Pharmacogenomics 8 329-337
[2007]
Evaluation of a microarray-based genotyping assay for the rapid detection of cytochrome P450 2C19 *2 and *3 polymorphisms from whole blood using nanoparticle probes
Buchan BW
Am J Clin Pathol 136 604-608
[2011]
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
Cytochrome P450 2C9polymorphisms: a comprehensive review of the in vitro and human data
Lee CR
Pharmacogenetics 12 251-263
[2002]
Comparison of performance of three commercial platforms for warfarin sensitivity genotyping
Babic N
Clin Chim Acta 406 143-147
[2009]
Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy
Avery PJ
Clin Pharmacol Ther 90 701-706
[2011]
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
'
Verigene Warfarin Metabolism Nucleic Acid Test Kit를 이용한 CYP2C9 및 VKORC1 유전형 분석능 평가'
의 유사주제(
) 논문